Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

731 questions in 61 reviews · Drugs and Alcohol

current versions
No studies 57 · 7.8%Ungraded 39 · 5.3%Very low 186 · 25.4%Low 239 · 32.7%Moderate 171 · 23.4%High 39 · 5.3%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Dialectic behaviour therapy with case management vs a health promotion scheme
Number not using crack at 6 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1 [0.87, 1.14]1 study · 116 participantsVery low
Dialectic behaviour therapy with case management vs a health promotion scheme
Number not using cocaine at 6 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.02 [0.93, 1.12]1 study · 116 participantsVery low
Dialectic behaviour therapy with case management vs a health promotion scheme
Number not using heroin at 6 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.05 [0.98, 1.13]1 study · 116 participantsVery low
Dialectic behaviour therapy with case management vs a health promotion scheme
Number not using methamphetamine at 6 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.02 [0.87, 1.2]1 study · 116 participantsVery low
Dialectic behaviour therapy with case management vs a health promotion scheme
Self‐report of no drug use at 6 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.2 [0.92, 1.56]1 study · 116 participantsVery low
Therapeutic community vs work release
Incarcerated for drug offences at 18 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.45 [0.87, 2.42]1 study · 112 participantsVery low
Therapeutic community vs work release
Marijuana use at 6 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.03 [0.19, 5.65]1 study · 51 participantsVery low
Therapeutic community vs work release
Marijuana use at 18 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1 [0.07, 14.45]1 study · 28 participantsVery low
Collaborative case management vs treatment
Number of arrests · female offenders
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.11 [0.83, 1.49]1 study · 113 participantsLow
Therapeutic community vs work release
Heroin use at 6 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.59 [0.49, 5.14]1 study · 68 participantsVery low
Therapeutic community vs work release
Heroin use at 18 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.92 [0.24, 15.37]1 study · 37 participantsVery low
Therapeutic community vs work release
Crack use at 6 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 2.07 [0.41, 10.41]1 study · 55 participantsVery low
Therapeutic community vs work release
Crack use at 18 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.64 [0.19, 14.06]1 study · 34 participantsVery low
Therapeutic community vs work release
Cocaine use at 6 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.09 [0.79, 1.5]1 study · 211 participantsLow
Therapeutic community vs work release
Cocaine use at 18 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 0.93 [0.64, 1.35]1 study · 139 participantsVery low
Intensive discharge planning and case management vs prison only
Marijuana use · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 0.79 [0.53, 1.16]1 study · 511 participantsModerate
Intensive discharge planning and case management vs prison only
Hard drug use · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.12 [0.88, 1.43]1 study · 511 participantsModerate
Intensive discharge planning and case management vs prison only
Positive hair test for crack cocaine · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
OR 1.08 [0.75, 1.54]1 study · 511 participantsModerate
Intensive discharge planning and case management vs prison only
Positive hair test for marijuana use · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 0.75 [0.55, 1.03]1 study · 511 participantsModerate
Community‐based buprenorphine vs placebo
End of treatment drug use · females offenders
Interventions for female drug‐using offenders (2019) · Cochrane
RR 0.57 [0.27, 1.2]1 study · 36 participantsVery low
Intensive discharge planning and case management vs prison only
Arrested · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 0.19 [0.04, 0.87]1 study · 511 participantsModerate
Intensive discharge planning and case management vs prison only
Drug charge · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.07 [0.75, 1.53]1 study · 511 participantsModerate
Intensive discharge planning and case management vs prison only
Incarceration · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 1.09 [0.86, 1.39]1 study · 511 participantsModerate
Pre‐ vs post‐release buprenorphine use
Heroin use and positive urine screen testing · 211 adults
Interventions for female drug‐using offenders (2019) · Cochrane
no estimate extracted1 study · 211 participantsLow
Community‐based buprenorphine vs placebo
Drug use at 3 months · females offenders
Interventions for female drug‐using offenders (2019) · Cochrane
RR 0.58 [0.25, 1.35]1 study · 36 participantsVery low
Interpersonal psychotherapy vs psychoeducational control
Relapse to drug use at 3 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 0.67 [0.3, 1.5]1 study · 38 participantsLow
Acceptance and commitment therapy (ACT) vs waiting list control
Abstinence from drug use at 6 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 2.89 [0.73, 11.43]1 study · 31 participantsLow
Acceptance and commitment therapy (ACT) vs waiting list control
ASI drug score at 6 months · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
no estimate extracted1 study · 31 participantsLow
Cognitive behavioural therapy and other therapies vs prison therapeutic community
Reincarcerated at 12 months after parole · summary findings of female review
Interventions for female drug‐using offenders (2019) · Cochrane
RR 0.7 [0.43, 1.12]1 study · 115 participantsLow
Family/parent interventions vs control
Alcohol use prevalence Up to 4 years post intervention impact of family/parent interventions compared to control on the prevalence of alcohol consumption or drunkenness · parents/children
Family‐based prevention programmes for alcohol use in young people (2019) · Cochrane
no estimate extracted12 studies · 7490 participantsLow
Family/parent interventions vs control
Alcohol use frequency Up to 4 years post intervention impact of family/parent interventions compared to control on the frequency of alcohol consumption · parents/children
Family‐based prevention programmes for alcohol use in young people (2019) · Cochrane
no estimate extracted8 studies · 1855 participantsVery low
Family/parent interventions vs control
Alcohol use volume Up to 4 years post intervention impact of family/parent interventions compared to control on the volume of alcohol consumption or drunkenness · parents/children
Family‐based prevention programmes for alcohol use in young people (2019) · Cochrane
no estimate extracted5 studies · 1825 participantsLow
Family/parent interventions vs control
Adverse events · parents/children
Family‐based prevention programmes for alcohol use in young people (2019) · Cochrane
no estimate extractedNRNo studies
Family/parent and adolescent interventions vs adolescent only interventions
Alcohol use prevalence Up to 4 years post intervention impact of family/parent interventions compared to control on the prevalence of alcohol consumption or drunkenness · parents and children
Family‐based prevention programmes for alcohol use in young people (2019) · Cochrane
no estimate extracted4 studies · 5640 participantsVery low
Family/parent and adolescent interventions vs adolescent only interventions
Alcohol use frequency Up to 4 years post intervention impact of family/parent interventions compared to control on the frequency of alcohol consumption · parents and children
Family‐based prevention programmes for alcohol use in young people (2019) · Cochrane
no estimate extracted4 studies · 915 participantsVery low
Family/parent and adolescent interventions vs adolescent only interventions
Adverse events · parents and children
Family‐based prevention programmes for alcohol use in young people (2019) · Cochrane
no estimate extractedNRNo studies
Brief intervention vs no or minimal intervention
Quantity of drinking (g/week) at 12 months · people with hazardous or harmful alcohol consumption as identified by a screening tool
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extracted34 studies · 15197 participantsModerate
Extended intervention vs brief intervention
Quantity of drinking (g/week) at 12 months · people with hazardous or harmful alcohol consumption
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extracted3 studies · 552 participantsLow
Extended intervention vs brief intervention
Frequency of binge drinking (no. binges/wk) at 12 months ‐ not measured · people with hazardous or harmful alcohol consumption
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extractedNRNo studies
Extended intervention vs brief intervention
Frequency of drinking (no. days drinking/week) at 12 months · people with hazardous or harmful alcohol consumption
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extracted1 study · 147 participantsLow
Extended intervention vs brief intervention
Intensity of drinking (g/drinking day) at 12 months · people with hazardous or harmful alcohol consumption
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extracted1 study · 147 participantsVery low
Brief intervention vs no or minimal intervention
Frequency of drinking (no. binges/wk) at 12 months · people with hazardous or harmful alcohol consumption as identified by a screening tool
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extracted15 studies · 6946 participantsModerate
Brief intervention vs no or minimal intervention
Frequency of drinking (no. days drinking/wk) at 12 months · people with hazardous or harmful alcohol consumption as identified by a screening tool
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extracted11 studies · 5469 participantsModerate
Brief intervention vs no or minimal intervention
Intensity of drinking (g/drinking day) at 12 months · people with hazardous or harmful alcohol consumption as identified by a screening tool
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extracted10 studies · 3128 participantsModerate
Brief intervention vs no or minimal intervention
Adverse effects · people with hazardous or harmful alcohol consumption as identified by a screening tool
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extracted5 studies · 5 participantsVery low
Extended intervention vs no or minimal intervention
Quantity of drinking (g/week) at 12 months · people with hazardous or harmful alcohol consumption
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extracted6 studies · 1296 participantsModerate
Extended intervention vs no or minimal intervention
Frequency of drinking (no. binges/wk) at 12 months · people with hazardous or harmful alcohol consumption
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extracted2 studies · 456 participantsModerate
Extended intervention vs no or minimal intervention
Frequency of drinking (no. days drinking/week) at 12 months · people with hazardous or harmful alcohol consumption
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extracted2 studies · 319 participantsModerate
Extended intervention vs no or minimal intervention
Intensity of drinking (g/drinking day) at 12 months · people with hazardous or harmful alcohol consumption
Effectiveness of brief alcohol interventions in primary care populations (2018) · Cochrane
no estimate extracted1 study · 158 participantsLow
Pharmacological detoxification treatment vs other pharmacological detoxification treatment
Completion of treatment: baclofen versus clonidine · management of opium withdrawal
Pharmacological therapies for management of opium withdrawal (2018) · Cochrane
RR 1.06 [0.63, 1.8]66 participantsVery low